Since 2021, I have worked as Platform Manager at the UmU data analytics platform CASP, supporting life science researchers with the analysis of experimental data using advanced data driven tools and strategies.
I completed my PhD in biochemistry and mass spectrometry at University College London (UCL) Great Ormond Street Institute of Child Health, focusing on the development of proteomic methods to investigate rare and common skin disorders. After this time, I worked as a Research Associate at the Clinical and Molecular Genetics Unit, UCL studying unique cases of diabetes in children. In 2011, I took the exciting step of moving to Sweden as part of a Marie Curie Initial Training Network, working as an Experienced Researcher at the company AcureOmics AB, specialising in the use of metabolomics for applications in health, disease and personalised medicine.
A large part of my work involved the development of mass spectrometry-based methods for metabolite and protein analysis. My expertise extends to multivariate data analysis and the biological interpretation of omics data to help understand disease mechanisms, with particular focus on rare genetic disorders and age-related diseases.
During my time at AcureOmics, I had the opportunity to manage and execute several EU projects including the Marie Curie Initial Training Network BOLD, FP7 projects BioMargin and HUMAN and the Horizon 2020 project BatCure. This gave me the opportunity to collaborate with a wide international network, which is something I thoroughly enjoyed and believe is a key part of research.
In 2022, I became a member of the steering board for Coalition Umeå for Life Science (CU4LS), helping bring together researchers, research centres and infrastructures from all areas of life science, which I've found to be both an exciting and fun role.